Champions Oncology - End to End Pharmacology Solutions

End to End Pharmacology Solutions
Bridging the Gap Between Research and Clinic

Leverage a range of research and development solutions to improve the productivity of oncology drug development

NSCLC PDX Ex Vivo Imaging & Cell Line In Vitro Screens
ENROLLMENT OPEN NOW THROUGH JAN 24th

Hematologic VitroScreen of Primary B-ALL Ex Vivo Models
ENROLLMENT OPEN NOW THROUGH JAN 31st

The CT26 HuSyngeneic Screen
ENROLLMENT OPEN NOW THROUGH JAN 31st

PDX Model Spotlight
EX20 EGFR Mutant Models

AACR 2019 Poster Presentation

AML PDX Platform to Evaluate Novel Therapeutic Agents

Our Latest Webinar

Clinical Flow Cytometry: Validation and Implementation in a Regulatory Setting

On-Demand Webinar Series

Learn more about humanized mouse models for the preclinical evaluation of novel immunotherapies

Access the Champions TumorGraft Database

Identify PDX cohorts based on molecular characteristics, patient treatment, standard-of-care testing outcomes, clinical features and more

Read Our Latest Newsletter

New Webinar!
Next Generation Humanzied Mice for AML and NK Cell Therapy Testing

Hematology
Oncology Models

Champions Oncology and PhenoVista Biosciences Announce a Strategic Partnership to provide Oncology Imaging-Based Phenotypic Assays...

Champions Oncology Partners with TransCure bioServices to Expand European Business and Operations